Development of a novel group of antiviral agents, acyclic nucleoside phosphonates, has provided a new perspective for treating human immunodeficiency virus (HIV) infection. One of the compounds, 9-(R)-[2-(phosphonomethoxy)propyl]adenine (PMPA) (tenofovir), has been shown to confer complete protection against AIDS in a simian model of the infection. The aim of our study was to investigate whether the antiviral efficacy of PMPA, which depends mainly on inhibition of virus-induced DNA polymerase or of reverse transcriptase, could be contributed by immunomodulatory potential of this drug. We screened for its ability to activate production of cytokines and chemokines that are known to interfere with the replication and/or the entry of HIV in cells. Using the in vitro test system of mouse macrophages and lymphocytes, it has been found that PMPA stimulates macrophage secretion of interleukin-1beta (IL-1beta), IL-10, and tumor necrosis factor alpha. Production of the chemokines RANTES and macrophage inflammatory protein 1alpha was activated in both macrophages and lymphocytes, and also in human cell line U937. Other cytokines--i.e., IL-2, IL-12, IL-13, and gamma interferon-remained uninfluenced by PMPA. The cytokines were stimulated in a dose-dependent fashion, with rapid onset, and peak concentrations were achieved within 5 to 24 h. The findings contribute to a more complex understanding of mechanisms of antiviral effectiveness of PMPA and support the view that this drug could become a promising candidate for therapeutic exploitation in anti-HIV preventive medicine.

Institute of Pharmacology Academy of Sciences of The Czech Republic Prague Czech Republic

Zobrazit více v PubMed

Arnó A, Ruiz L, Juan M, Jou A, Balagué M, Zayat M K, Marfil S, Martínez-Picado J, Martínez M A, Romeu J, Pujol-Borell R, Lane C, Clotet B. Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with <250/μL CD4 T cells and undetectable plasma virus load. J Infect Dis. 1999;180:56–60. PubMed

Bailer R T, Lee B, Montaner L J. IL-13 and TNF-α inhibit dual-tropic HIV-1 in primary macrophages by reduction of surface expression of CD4, chemokine receptors CCR5, CXCR4 and post-entry viral gene expression. Eur J Immunol. 2000;30:1340–1349. PubMed

Balzarini J, Aquaro S, Perno C F, Witvrouw M, Holý A, De Clercq E. Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems. Biochem Biophys Res Commun. 1996;219:337–341. PubMed

Barker E, Mackewicz C E, Levy J A. Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci USA. 1995;92:11135–11139. PubMed PMC

Berger E A, Murphy P M, Farber J M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol. 1999;17:657–700. PubMed

Bischofberger N, Tsai C-C, Sabo A, Follis K E, Grant R F, Beck T W, Dailey P J, Black R. Antiviral efficacy of PMPA in macaques chronically infected with SIV. Antivir Res. 1996;30:A42. . (Abstract.)

Cammack N. Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target. Antivir Chem Chemother. 1999;10:53–62. PubMed

Capobianchi M R, Abbate I, Antonelli G, Turriziani O, Dolei A, Dianzani F. Inhibition of HIV type 1 BaL replication by MIP-1α, MIP-1β, and RANTES in macrophages. AIDS Res Hum Retrovir. 1998;14:233–240. PubMed

Cassatella M A, Meda L, Gasperini S, Calzetti F, Bonora S. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med. 1994;179:1695–1699. PubMed PMC

Clerici M, Lucey D R, Berzofsky J A, Pinto L A, Wynn T A, Blatt S P, Dolan M J, Hendrix C W, Wolf S F, Shearer G M. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science. 1993;262:1721–1724. PubMed

Cocchi F, DeVico A L, Garzino Demo A, Arya S K, Gallo R C, Lusso P. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science. 1995;270:1811–1815. PubMed

Collier A C, Coombs R W, Nienow J, Paradise M, Yang H H, Troxel S, Boggs J, Ebeling D, Jaffe H S, Corey L. Phase I/II study of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in advanced HIV infection. 1993. The First National Conference on Human Retroviruses and Related Infections. Bethesda, Md.

Corley P A. Interleukin-1 receptor antagonist as a treatment of HIV infection. Med Hypotheses. 2000;54:513–518. PubMed

Cota M, Mengozzi M, Vicenzi E, Panina-Bordignon P, Sinigaglia F, Transidico P, Sozzani S, Mantovani A, Poli G. Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine. Proc Natl Acad Sci USA. 2000;97:9162–9167. PubMed PMC

Cundy K C. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet. 1999;36:127–143. PubMed

Cundy K C, Barditch-Crovo P A, Walker A C, Collier D, Ebeling D, Toole J, Jaffe H S. Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients. Antimicrob Agents Chemother. 1995;39:2401–2405. PubMed PMC

Deeks S G, Barditch-Crovo P, Lietman P S, Hwang F, Cundy K C, Rooney J F, Hellmann N S, Safrin S, Kahn J O. Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults. Antimicrob Agents Chemother. 1998;42:2380–2384. PubMed PMC

Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton R E, Hill C M, Davis C B, Peiper S C, Schall T J, Littman D R, Landau N R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996;381:661–666. PubMed

de Waal Malefyt R, Abrams J, Bennett B, Figdor C G, de Vries J. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10-produced by monocytes. J Exp Med. 1991;174:1209–1220. PubMed PMC

Dhawan S, Heredia A, Wahl L M, Epstein J S, Meltzer M S, Hewlett I K. Interferon-gamma-induced downregulation of CD4 inhibits the entry of human immunodeficiency virus type-1 in primary monocytes. Pathobiology. 1995;63:93–99. PubMed

Dinarello C A, Cannon J G, Wolff S M. Tumor necrosis factor/cachectin is an endogenous pyrogen and induces production of interleukin-1. J Exp Med. 1986;163:1433–1450. PubMed PMC

Dragic T, Litwin V, Allaway G P, Martin S R, Huang Y, Nagashima K A, Cayanan C, Maddon P J, Koup R A, Moore J P, Paxton W A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 1996;381:667–673. PubMed

Duh E J, Maury W J, Folks T M, Fauci A S, Rabson A B. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci USA. 1989;86:5974–5978. PubMed PMC

Fauci A S. An elusive soluble suppressor. Nature. 1995;378:561. PubMed

Feng Y, Broder C C, Kennedy P E, Berger E A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996;272:872–877. PubMed

Galli G, Annunziato F, Mavilia C, Romagnani P, Cosmi L, Manetti R, Pupilli C, Maggi E, Romagnani S. Enhanced HIV expression during Th2-oriented responses explained by the opposite regulatory effect of IL-4 and IFN-γ on fusin/CXCR4. Eur J Immunol. 1998;28:3280–3290. PubMed

Ghassemi M, Asadi F K, Andersen B R, Novak R M. Mycobacterium avium induces HIV upregulation through mechanisms independent of cytokine induction. AIDS Res Hum Retrovir. 2000;16:435–440. PubMed

Haraguchi S, Good R A, Cianciolo G J, Engelman R W, Day N K. Immunosuppressive retroviral peptides: Immunopathological implications for immunosuppressive influences of retroviral infections. J Leukoc Biol. 1997;61:654–666. PubMed

Hartmann K A, Donath A, Beer B, Egberink H F, Horzinek M C, Lutz H, Hoffmann-Fezer G, Thum I, Thefeld S. Use of two virostatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms. Vet Immunol Immunopathol. 1992;35:167–175. PubMed

Hermann E, Darcissac E, Idziorek T, Capron A, Bahr G M. Recombinant interleukin-16 selectively modulates surface receptor expression and cytokine release in macrophages and dendritic cells. Immunobiology. 1999;97:241–248. PubMed PMC

Holý A, Masojídková M. Synthesis of enantiomeric N-(2-phosphonomethoxypropyl) derivatives of purine and pyrimidine bases. 1. The stepwise approach. Collect Czech Chem Commun. 1995;60:1196–1212.

Holý A, Votruba I, Merta A, Èerný J, Veselý J, Vlach J, Šedivá K, Rosenberg I, Otmar M, Høebabecký H, Trávníèek M, Vonka V, Snoeck R, De Clercq E. Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro. Antivir Res. 1990;13:295–311. PubMed

Hornung F, Scala G, Lenardo M J. TNF-α-induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytes. J Immunol. 2000;164:6180–6187. PubMed

Hu S X, Chao C C, Ehrich L C, Sheng W S, Sutton R L, Rockswold G L, Peterson P K. Inhibition of microglial cell RANTES production by IL-10 and TGF-β. J Leukoc Biol. 1999;65:815–821. PubMed

Chang J, Naif H M, Li S, Jozwiak R, HoShon M, Cunningham A L. The inhibition of HIV replication in monocytes by interleukin 10 is linked to inhibition of cell differentiation. AIDS Res Hum Retrovir. 1996;12:1227–1236. PubMed

Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath P D, Wu L, Mackay C R, LaRosa G, Newman W, Gerard N, Gerard C, Sodorski J. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 1996;85:1135–1148. PubMed

Joyce D A, Gibbons D P, Green P, Steer J H, Feldmann M, Brennan F M. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol. 1994;24:2699–2705. PubMed

Lane B R, Markovitz D M, Woodford N L, Rochford R, Strieter R M, Coffey M J. TNF-α inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J Immunol. 1999;163:3653–3661. PubMed

Lefebvre D‘Hellencourt C, Diaw L, Cornillet P, Guenounou M. Differential regulation of TNFα, IL-1β, IL-6, IL-8, TNFβ, and IL-10 by pentoxifylline. Int J Immunopharmacol. 1996;18:739–748. PubMed

Merta A, Votruba I, Rosenberg I, Otmar M, Høebabeck. ı H, Bernaerts R, Holý A. Inhibition of herpes simplex virus DNA polymerase by diphosphates of acyclic phosphonylmethoxyalkyl nucleotide analogues. Antiviral Res. 1990;13:209–218. PubMed

Miyamoto N G, Medberry P S, Hesselgesser J, Boehlk S, Nelson P J, Krensky A M, Perez H D. Interleukin-1β induction of the chemokine RANTES promoter in the human astrocytoma line CH235 requires both constitutive and inducible transcription factors. J Neuroimmunol. 2000;105:78–90. PubMed

Montaner L J, Dozle A G, Collin M, Herbein G, Illei P, James W, Minty A, Caput D, Ferrara P. Interleukin 13 inhibits human immunodeficiency virus type I production in primary blood-derived human macrophages in vitro. J Exp Med. 1993;178:743–747. PubMed PMC

Penn M L, Grivel J-C, Schramm B, Goldsmith M A, Margolis L. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. Proc Natl Acad Sci USA. 1999;96:663–668. PubMed PMC

Poli G, Kinter A L, Fauci A S. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonists. Proc Natl Acad Sci USA. 1994;91:108–112. PubMed PMC

Poli G, Kinter A L, Justement J S, Kehrl J H, Bressler P, Stanley S, Fauci A S. Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA. 1990;87:782–785. PubMed PMC

Rabbi M F, Finnegan A, Al-Harthi L, Song S, Roebuck K A. Interleukin-10 enhances tumor necrosis factor-α activation of HIV-1 transcription in latently infected cells. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:321–331. PubMed

Rohr O, Schwartz C, Aunis D, Schaeffer E. CREB and COUP-TF mediate transcriptional activation of the human immunodeficiency virus type 1 genome in Jurkat T cells in response to cyclic AMP and dopamine. J Cell Biochem. 1999;75:404–413. PubMed

Saville M W, Taga K, Foli A, Broder S, Tosato G, Yarchoan R. Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage. Blood. 1994;83:3591–3599. PubMed

Schuitemaker H. IL4 and IL10 as potent inhibitors of HIV1 replication in macrophages in vitro: a role for cytokines in the in vivo virus host range? Res Immunol. 1994;145:588–592. PubMed

Silvera P, Racz P, Racz K, Bischofberger N, Crabbs C, Yalley-Ogunro J, Greenhouse J, Jiang J B, Lewis M G. Effect of PMPA and PMEA on the kinetics of viral load in simian immunodeficiency virus-infected macaques. AIDS Res Hum Retrovir. 2000;16:791–800. PubMed

Tsai C-C, Follis K E, Sabo A, Beck T W, Grant R F, Bischofberger N, Benveniste R E, Black R. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science. 1995;270:1197–1199. PubMed

Tsai C-C, Follis K E, Sabo A, Grant R F, Bartz C, Notte R E, Benveniste R E, Bischofberger N. Preexposure prophylaxis with of 9-(2-phosphonylmethoxyethyl)adenine against simian immunodeficiency virus infection in macaques. J Infect Dis. 1994;169:260–266. PubMed

Van Rompay K K A, Berardi C J, Aguirre N L, Bischofberger N, Lietman P S, Pedersen N C, Marthas M L. Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection. AIDS. 1998;12:F79–F83. PubMed

Van Rompay K K A, Miller M D, Marthas M L, Margot N A, Dailey P J, Canfield D R, Tarara R P, Cherrington J M, Aguirre N L, Bischofberger N, Pedersen N C. Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA. J Virol. 2000;74:1767–1774. PubMed PMC

Votruba I, Trávníèek M, Rosenberg I, Otmar M, Merta A, Høebabecký H, Holý A. Inhibition of avian myeloblastosis virus reverse transcriptase by diphosphates of acyclic phosphonylmethyl nucleotide analogues. Antivir Res. 1990;13:287–293. PubMed

Walker R E, Vogel S E, Jaffe H S, Polis M A, Kovacs J A F J, Davey R T, Ebeling D, Cundy K C, Paar D, Markowitz N, Masur H, Lane H C. A phase I/II study of PMEA in HIV infected patients. 1993. The First National Conference on Human Retroviruses and Related Infections. Bethesda, Md.

Wanidworanum C, Strober W. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol. 1993;151:6853–6861. PubMed

Weissman D, Poli G, Fauci A S. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:442–449. PubMed

Weissman D, Poli G, Fauci A S. Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. AIDS Res Hum Retrovir. 1994;10:1199–1206. PubMed

Wong G H W, Kamb A, Goeddel D V. Antiviral properties of TNF. In: Beutler B, editor. Tumor necrosis factors: the molecules and their emerging role in medicine. New York, N.Y: Raven Press, Ltd; 1992. pp. 371–381.

Xiao B-G, Mousa A, Kivisäkk P, Seiger A, Bakhiet M, Link H. Induction of β-family chemokines mRNA in human embryonic astrocytes by inflammatory cytokines and measles virus protein. J Neurocytol. 1998;27:575–580. PubMed

Yang A G, Zhang X, Torti F, Chen S Y. Anti-HIV type 1 activity of wild-type and functional defective RANTES intrakine in primary human lymphocytes. Hum Gene Ther. 1998;9:2005–2018. PubMed

Ylisastigui L, Vizzavona J, Drakopoulou E, Paindavoine P, Calvo C F, Parmentier M, Gluckman J C, Vita C, Benjouad A. Synthetic full-length and truncated RANTES inhibit human immunodeficiency virus type 1 infection of primary macrophages. AIDS. 1998;12:977–984. PubMed

Zídek Z, Franková D, Holý A. Activation of cytokine production by antiviral acyclic nucleoside phosphonates. Eur Cytokine Netw. 2000;11(Special issue):189.

Zídek Z, Holý A, Franková D. Immunomodulatory properties of antiviral acyclic nucleotide analogues: cytokine stimulatory and nitric oxide costimulatory effects. Int J Immunopharmacol. 1997;19:587–597. PubMed

Nucleobase Modified Adefovir (PMEA) Analogues as Potent and Selective Inhibitors of Adenylate Cyclases from Bordetella pertussis and Bacillus anthracis

Design and Synthesis of Fluorescent Acyclic Nucleoside Phosphonates as Potent Inhibitors of Bacterial Adenylate Cyclases